China Archives | Page 23 of 102 | Be Korea-savvy
Baidu Still Refuses to Correct Nationality of Korean Poet

Baidu Still Refuses to Correct Nationality of Korean Poet

SEOUL, Dec. 31 (Korea Bizwire) — Chinese internet search behemoth Baidu has been rejecting requests to correct Korean poet Yun Dong-ju (1917-1945)’s nationality over the past year. Baidu introduces Yun, as well as Korean independence fighters Lee Bong-chang (1900-1932) and Yun Bong-gil (1908-1932) as of Chinese nationality and lists their ethnic group as “Joseonjok” or [...]

Most S. Koreans Do Not Like China, Yoon Says

Most S. Koreans Do Not Like China, Yoon Says

SEOUL, Dec. 28 (Korea Bizwire) — Most South Koreans, especially younger people, don’t like China even though the administration of President Moon Jae-in has pursued pro-China policies, main opposition presidential candidate Yoon Suk-yeol said Tuesday. Yoon of the People Power Party (PPP) made the remarks during a discussion hosted by the American Chamber of Commerce [...]

Majority of S. Korean Businesses in China Struggle with Discrimination: Survey

Majority of S. Korean Businesses in China Struggle with Discrimination: Survey

SEOUL, Dec. 23 (Korea Bizwire) — A majority of South Korean businesses in China are struggling with a rapidly deteriorating environment for local investment as well as regulatory discrimination compared to Chinese competitors, a major Korean business lobby group said Wednesday. The Federation of Korean Industries conducted a survey of 131 businesses (excluding financial firms) [...]

Hyundai Motor Group Tops China’s CSR List for 6th Straight Year

Hyundai Motor Group Tops China’s CSR List for 6th Straight Year

SEOUL, Dec. 6 (Korea Bizwire) — Hyundai Motor Group ranked first on a list measuring carmakers’ corporate social responsibility (CSR) activities in China for the sixth consecutive year. The South Korea’s top automotive conglomerate, which has Hyundai Motor Co. and Kia Corp. under its wing, announced that in the 2021 China CSR development index evaluated [...]

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma

SHANGHAI, China, Nov. 30 (Korea Bizwire) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) announced today that the National Medical Products Administration (NMPA) of China has approved its supplemental New Drug Application (sNDA) for toripalimab in combination with cisplatin and gemcitabine as the first-line treatment for patients with locally recurrent or [...]